Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Support

This activity is supported by an educational grant from Takeda Oncology.

BURST CME™: Deciphering Clinical Trial Endpoints Amidst an Advent of Novel Therapies for Low- to High-Risk MDS

Release Date: December 21, 2021
Expiration Date: December 21, 2022

Activity Overview

Recent years have brought several new treatment options for patients with myelodysplastic syndromes (MDS). Drug development and ongoing clinical trials investigate new therapeutics and rational combination strategies, but design and interpretation of these trials can be challenging as MDS is a heterogenic disease affecting an older population often with extensive comorbidities and unique goals of therapy. Clinically meaningful trial endpoints for these patients are associated with substantial duration of response, improvement in quality of life and prolonged survival. Measures of response frequently utilized in MDS trials may not always capture these patient-focused endpoints. It is essential for health care providers to be able to interpret the impact of trial endpoints amidst an advent of data and novel advances for the treatment and management of MDS.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Takeda Oncology.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This educational program is directed toward hematologists and medical oncologists interested in the treatment of hematologic malignancies. Other allied healthcare professionals, including nurse practitioners, physician assistants, nurses, and other healthcare professionals involved in the treatment and management of patients with hematologic malignancies will also be invited to participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to

  • Summarize the criteria for myelodysplastic syndrome (MDS) treatment and response assessment utilized in clinical trials as endpoints
  • Discuss endpoints utilized from recent clinical trials aimed at honing treatment in MDS based on risk stratification
  • Evaluate recent efficacy and safety results from trials that assessed evolving approaches for MDS management
  • Explain the clinical impact of recent trial findings in the context of trial endpoints and how they are shaping evolving treatment pathways in MDS care

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies. 


Gabriel Schwartz, MSN, FNP-BC, AOCNP
Mikkael A. Sekeres, MD
Chief, Division of Hematology
Sylvester Comprehensive Cancer Center
University of Miami Health System
Miami, FL

Disclosures: Consultant: Celgene/Bristol Myers Squibb, Novartis, Pfizer, Syros Pharmaceuticals.

PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By